Registration of APIs CMC information required for an IND
IND and NDA support Drug master files (DMF) filing
Synonyms/Alias | Z-LEU-LEU-OH;7801-71-0;(S)-2-((S)-2-(((Benzyloxy)carbonyl)amino)-4-methylpentanamido)-4-methylpentanoic acid;CHEMBL203568;(2S)-4-methyl-2-[[(2S)-4-methyl-2-(phenylmethoxycarbonylamino)pentanoyl]amino]pentanoic acid;N-((Phenylmethoxy)carbonyl)-L-leucyl-L-leucine;N-[(Phenylmethoxy)carbonyl]-L-leucyl-L-leucine;MFCD00038296;N-Cbz-L-Leu-L-Leu-OH;N-Cbz-L-leucinyl-L-leucine;SCHEMBL4872585;BDBM50179750;AKOS016014308;N-Benzyloxycarbonyl-L-leucyl-L-leucine;AS-56436;NS00046929;G77533;(S)-2-((S)-2-(benzyloxycarbonyl)-4-methylpentanamido)-4-methylpentanoic acid;(S)-2-((S)-2-(benzyloxycarbonylamino)-4-methylpentanamido)-4-methylpentanoic acid; |
M.F/Formula | C20H30N2O5 |
M.W/Mr. | 378.5 |
Sequence | One Letter Code:LL Three Letter Code:Cbz-Leu-Leu-OH |
InChI | InChI=1S/C20H30N2O5/c1-13(2)10-16(18(23)21-17(19(24)25)11-14(3)4)22-20(26)27-12-15-8-6-5-7-9-15/h5-9,13-14,16-17H,10-12H2,1-4H3,(H,21,23)(H,22,26)(H,24,25)/t16-,17-/m0/s1 |
InChI Key | XGJGWYRHLPSMLW-IRXDYDNUSA-N |
Required fields are marked with *
×If you have any peptide synthesis requirement in mind, please do not hesitate to contact us. We will endeavor to provide highly satisfying products and services.